Hilyatuz Zahroh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hilyatuz Zahroh has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Usman Sumo Friend Tambunan
Universitas Indonesia
2 shared publications Adi Riyadahi
1 shared publication- Agus Salim
Faculty of Science and Technology, Syarif Hidayatullah State Islamic University (UIN) Jakarta
1 shared publication Ahmad Ma'RUp
Department of Chemistry, Universitas Islam Negeri Syarif Hidayatullah, Indonesia
1 shared publicationAnnette McGrath
CSIRO DATA61, Brisbane, Australia
1 shared publicationAril Aditya Parikesit
Bioinformatics Research Group, Department of Chemistry, Faculty of Mathematics and Science, University of Indonesia, Indonesia
1 shared publication
Latest Publications
- Open Access
- 11 July 2025
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 13 (4) , e70121
Pharmacogenomics Education and Knowledge Assessment in Healthcare Curricula: A Scoping Review of the Middle East and North Africa Region
Pharmacogenomics (PGx) is a crucial part of precision medicine; however, its integration into clinical practice has been slow, primarily due to knowledge gaps regarding pharmacogenomics among healthcare professionals (HCPs). Pharmacogenomics education is considered the most influential barrier to the successful implementation of PGx. In the Middle East and North Africa (MENA) region, several studies have highlighted the lack of PGx education among students and HCPs. This scoping review aims to provide an overview of the existing literature on how PGx is delivered in the curricula and its impact on knowledge acquisition among students and HCPs in the MENA region. A database search of PubMed, Embase, and CINAHL was conducted up to June 2023. Outcomes included PGx education availability, curriculum placement, mode of delivery, and knowledge level. Seven cross‐sectional studies were identified (2014–2023), with 57% from the Gulf region. PGx education is mostly taught to undergraduates (71%) through didactic lectures (100%), with only a few studies reporting a standalone course (29%). Participants demonstrated low (43%) to moderate (43%) knowledge levels, assessed using objective scales or subjective self‐assessment after completion of the course. Reported barriers to implementing PGx education included knowledge gaps, economic constraints, and system sustainability. PGx education in the MENA region is delivered mainly as an integrated course in professional programs including pharmacy and medicine, and the overall knowledge level was low to moderate. Future research could focus on providing more detailed reporting of the PGx educational landscape, developing standardized assessment tools, and evaluating actual knowledge acquisition among different professions.
- 11 July 2025
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 13 (4) , e70121
Open AccessPharmacogenomics Education and Knowledge Assessment in Healthcare Curricula: A Scoping Review of the Middle East and North Africa Region
Pharmacogenomics (PGx) is a crucial part of precision medicine; however, its integration into clinical practice has been slow, primarily due to knowledge gaps regarding pharmacogenomics among healthcare professionals (HCPs). Pharmacogenomics education is considered the most influential barrier to the successful implementation of PGx. In the Middle East and North Africa (MENA) region, several studies have highlighted the lack of PGx education among students and HCPs. This scoping review aims to provide an overview of the existing literature on how PGx is delivered in the curricula and its impact on knowledge acquisition among students and HCPs in the MENA region. A database search of PubMed, Embase, and CINAHL was conducted up to June 2023. Outcomes included PGx education availability, curriculum placement, mode of delivery, and knowledge level. Seven cross‐sectional studies were identified (2014–2023), with 57% from the Gulf region. PGx education is mostly taught to undergraduates (71%) through didactic lectures (100%), with only a few studies reporting a standalone course (29%). Participants demonstrated low (43%) to moderate (43%) knowledge levels, assessed using objective scales or subjective self‐assessment after completion of the course. Reported barriers to implementing PGx education included knowledge gaps, economic constraints, and system sustainability. PGx education in the MENA region is delivered mainly as an integrated course in professional programs including pharmacy and medicine, and the overall knowledge level was low to moderate. Future research could focus on providing more detailed reporting of the PGx educational landscape, developing standardized assessment tools, and evaluating actual knowledge acquisition among different professions.
- 11 August 2023
- Published by Springer Nature in Nature Biotechnology
- Vol. 41 (8) , 1171-1174
Grand challenges in bioinformatics education and training
- 11 August 2023
- Published by Springer Nature in Nature Biotechnology
- Vol. 41 (8) , 1171-1174
Grand challenges in bioinformatics education and training
- 1 July 2018
- Published by Wolters Kluwer Health in Pharmacogenetics and Genomics
- Vol. 28 (7) , 167-176
NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury
NAT2 slow acetylator is a confirmed risk of anti-tuberculosis drug-induced liver injury (ATDILI). However, NAT2 ultra-slow acetylators, a new refinement among NAT2 slow acetylators, have been recently proposed. The patients with NAT2 genotypes of *6A/*6A, *6A/*7B and *7B/*7B are referred to in this group. We aim to prove an association of the NAT2 ultra-slow acetylators with the risk of ATDILI. Systematic review and meta-analysis were performed based on each NAT2 genotype and risk of ATDILI cases and also new classification of the ultra-slow acetylators up to 31 October 2016. Meta-analysis of 18 studies with 822 ATDILI cases and 4630 controls was carried out in the RevMan software, version 5.3 with fixed-effect (low heterogeneity) and random effect (moderate to high heterogeneity) methods. The strong associations between each NAT2 slow acetylator genotypes and ATDILI were confirmed in meta-analysis except for NAT2*5B/*5B [odds ratio (OR): 1.69; 95% confidence interval (CI): 0.96-2.95; P=0.0679]. The NAT2 ultra-slow acetylators contribute to higher risk of ATDILI (OR: 3.60; 95% CI: 2.30-5.63; P=1.76E-08) than all NAT2 slow acetylators (OR: 2.80; 95% CI: 2.20-3.57; P=5.73E-18) as well as fast acetylators. Additional in-vitro study using isoniazid as a substrate supports the existence of ultra-slow acetylator alleles (NAT2*6A and NAT2*7B). This is the first meta-analysis of NAT2 and the risk of ATDILI at the genotypic level. The result demonstrated that NAT2 ultra-slow acetylator genotypes will have the most effect on the increased risk of ATDILI.
- 1 July 2018
- Published by Wolters Kluwer Health in Pharmacogenetics and Genomics
- Vol. 28 (7) , 167-176
NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury
NAT2 slow acetylator is a confirmed risk of anti-tuberculosis drug-induced liver injury (ATDILI). However, NAT2 ultra-slow acetylators, a new refinement among NAT2 slow acetylators, have been recently proposed. The patients with NAT2 genotypes of *6A/*6A, *6A/*7B and *7B/*7B are referred to in this group. We aim to prove an association of the NAT2 ultra-slow acetylators with the risk of ATDILI. Systematic review and meta-analysis were performed based on each NAT2 genotype and risk of ATDILI cases and also new classification of the ultra-slow acetylators up to 31 October 2016. Meta-analysis of 18 studies with 822 ATDILI cases and 4630 controls was carried out in the RevMan software, version 5.3 with fixed-effect (low heterogeneity) and random effect (moderate to high heterogeneity) methods. The strong associations between each NAT2 slow acetylator genotypes and ATDILI were confirmed in meta-analysis except for NAT2*5B/*5B [odds ratio (OR): 1.69; 95% confidence interval (CI): 0.96-2.95; P=0.0679]. The NAT2 ultra-slow acetylators contribute to higher risk of ATDILI (OR: 3.60; 95% CI: 2.30-5.63; P=1.76E-08) than all NAT2 slow acetylators (OR: 2.80; 95% CI: 2.20-3.57; P=5.73E-18) as well as fast acetylators. Additional in-vitro study using isoniazid as a substrate supports the existence of ultra-slow acetylator alleles (NAT2*6A and NAT2*7B). This is the first meta-analysis of NAT2 and the risk of ATDILI at the genotypic level. The result demonstrated that NAT2 ultra-slow acetylator genotypes will have the most effect on the increased risk of ATDILI.
- Open Access
- 18 December 2017
- Published by Universitas Gadjah Mada in Jurnal Pengabdian kepada Masyarakat (Indonesian Journal of Community Engagement)
- Vol. 3 (1) , 77-85
Media Edukasi Berbasis Cetak dan Digital Tentang Pengobatan Lepra dan Efek Samping Obat Mempermudah Pemahaman Penderita Lepra, Keluarga, Masyarakat dan Tenaga Kesehatan di Tanjung Pasir Tentang Lepra dan Terapinya
Leprosy can be cured with multi-drug therapy as recommended by WHO. However, the presence of leprosy stigma prevents people from obtaining early detection and proper treatment. Furthermore, the adverse effect of leprosy treatment on certain individuals with genetic susceptibility, known as dapsone hypersensitivity syndrome, is often presumed as a malpractice. This further lowered people willingness to seek medical help. The reluctance to cure the disease could worsen the disease condition and spread it to their community. To overcome these problems, there should be efforts to disseminate medical information to community which discuss about leprosy treatment and its possible adverse effect. In this activity we, together with Puskesmas Desa Tegal Angus, informed and educated leprosy patients, their family and their neighbouring community with the help of educational media in the form of print and digital media. The aim of this activity was to share correct information on leprosy and the urgency of leprosy treatment, which in turn would reduce leprosy stigma and increase the patients’ willingness to complete their full course of treatment. According to the test result, people gained improved understanding about leprosy, especially in term of its definition, its transmission and treatment, factors that influence its susceptibility (including genetic factor) and how to avoid deformity due to leprosy.
- 18 December 2017
- Published by Universitas Gadjah Mada in Jurnal Pengabdian kepada Masyarakat (Indonesian Journal of Community Engagement)
- Vol. 3 (1) , 77-85
Open AccessMedia Edukasi Berbasis Cetak dan Digital Tentang Pengobatan Lepra dan Efek Samping Obat Mempermudah Pemahaman Penderita Lepra, Keluarga, Masyarakat dan Tenaga Kesehatan di Tanjung Pasir Tentang Lepra dan Terapinya
Leprosy can be cured with multi-drug therapy as recommended by WHO. However, the presence of leprosy stigma prevents people from obtaining early detection and proper treatment. Furthermore, the adverse effect of leprosy treatment on certain individuals with genetic susceptibility, known as dapsone hypersensitivity syndrome, is often presumed as a malpractice. This further lowered people willingness to seek medical help. The reluctance to cure the disease could worsen the disease condition and spread it to their community. To overcome these problems, there should be efforts to disseminate medical information to community which discuss about leprosy treatment and its possible adverse effect. In this activity we, together with Puskesmas Desa Tegal Angus, informed and educated leprosy patients, their family and their neighbouring community with the help of educational media in the form of print and digital media. The aim of this activity was to share correct information on leprosy and the urgency of leprosy treatment, which in turn would reduce leprosy stigma and increase the patients’ willingness to complete their full course of treatment. According to the test result, people gained improved understanding about leprosy, especially in term of its definition, its transmission and treatment, factors that influence its susceptibility (including genetic factor) and how to avoid deformity due to leprosy.
- Open Access
- 30 September 2016
- Published by Universiti Teknologi PETRONAS in International Journal of Biomass and Renewables
- Vol. 5 (2) , 23
Extraction of Isovitexin from Melinjo (Gnetum Gnemon L.) Leaves Using Mixtures of Liquid Carbon Dioxide and Ethanol
- 30 September 2016
- Published by Universiti Teknologi PETRONAS in International Journal of Biomass and Renewables
- Vol. 5 (2) , 23
Open AccessExtraction of Isovitexin from Melinjo (Gnetum Gnemon L.) Leaves Using Mixtures of Liquid Carbon Dioxide and Ethanol
- Open Access
- 1 January 2016
- Published by Aboutscience Srl in Drug Target Insights
- Vol. 10, DTI.S38458-29
Immunoinformatics Approach in Designing Epitope-based Vaccine against Meningitis-inducing Bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae Type b)
Meningitis infection is one of the major threats during Hajj season in Mecca. Meningitis vaccines are available, but their uses are limited in some countries du...
- 1 January 2016
- Published by Aboutscience Srl in Drug Target Insights
- Vol. 10, DTI.S38458-29
Open AccessImmunoinformatics Approach in Designing Epitope-based Vaccine against Meningitis-inducing Bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae Type b)
Meningitis infection is one of the major threats during Hajj season in Mecca. Meningitis vaccines are available, but their uses are limited in some countries du...
- Open Access
- 1 January 2015
- Published by Aboutscience Srl in Drug Target Insights
- Vol. 9, DTI.S31566-49
Screening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2
Dengue is an infectious disease caused by dengue virus (DENV) and transmitted between human hosts by mosquitoes. Recently, Indonesia was listed as a country wit...
- 1 January 2015
- Published by Aboutscience Srl in Drug Target Insights
- Vol. 9, DTI.S31566-49
Open AccessScreening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2
Dengue is an infectious disease caused by dengue virus (DENV) and transmitted between human hosts by mosquitoes. Recently, Indonesia was listed as a country wit...